Congratulations to Prof. Davide Rossi on his publication in BLOOD

Congratulations to Prof. Davide Rossi at IOSI (Istituto Oncologico della Svizzera Italiana – EOC) and all the teams involved in the SAKK 34/17 trial. The results of this study have recently been published in BLOOD. 

This research, supported by the ISREC Foundation, has led to the development of a new therapeutic approach for patients with relapsed or refractory chronic lymphocytic leukemia. It involves an extended initial course of ibrutinib, followed by a combination therapy with venetoclax.

This strategy leads to better tumor control, a higher rate of complete remissions and a lower risk of tumor lysis syndrome.

Read the article here: https://lnkd.in/eZ5DqxAK